Altimmune Balance Sheet Health
Financial Health criteria checks 6/6
Altimmune has a total shareholder equity of $194.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $210.6M and $16.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$197.82m |
Equity | US$194.10m |
Total liabilities | US$16.54m |
Total assets | US$210.64m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 3G0's short term assets ($209.6M) exceed its short term liabilities ($12.1M).
Long Term Liabilities: 3G0's short term assets ($209.6M) exceed its long term liabilities ($4.4M).
Debt to Equity History and Analysis
Debt Level: 3G0 is debt free.
Reducing Debt: 3G0 has no debt compared to 5 years ago when its debt to equity ratio was 1.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 3G0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 3G0 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 32.8% each year.